[ad_1] Energy prices are surging, and an income-oriented play is getting some love from legendary investor Bill Gross. Earlier this month, the former Pimco investment chief and ” bond king ” said on social media platform X : “I love MLP pipelines …. Better than AI,” noting that these master limited partnerships have climbed by double-digits in the past 12 months. The action in MLPs is getting some help as energy prices jump. West Texas Intermediate crude futures have popped nearly 20% in 2024 and Brent futures have surged 16% as conflict in the Middle East escalates and oil cartel…
Author: whatnews
[ad_1] Spencer Platt/Getty Images News U.S. stocks on Tuesday slipped, weighed down by the financial sector ahead of key earnings reports later this week. Market participants also exhibited caution a day before the latest consumer inflation data. Wall Street’s three major averages opened in the green but quickly reversed course after. The tech-heavy Nasdaq Composite (COMP:IND) was last down 0.17% to 16,225.73 points in afternoon trade, while the benchmark S&P 500 (SP500) was lower by 0.32% to 5,185.89 points. The blue-chip Dow (DJI) fell 0.34% to 38,761.21 points. Of the 11 S&P sectors, seven were in the red. Financials fell…
[ad_1] Analysts still expect a ‘messy’ first quarter and say second-quarter expectations are too high [ad_2] Source link
[ad_1] As the April 15 tax deadline approaches, more investors are making investments in their future by making last-minute contributions to individual retirement accounts. [ad_2] Source link
[ad_1] Investors may want to pick up shares in companies that can withstand a possible inflation comeback. The second quarter is off to a rough start as investors have become increasingly wary about higher-for-longer interest rates and stickier inflation. The S & P 500 is down 1.5% so far this month, while the 30-stock Dow has lost nearly 3% and the Nasdaq has shed 1.1%. Prices of most commodities, from gold to crude oil, have also increased to new highs in recent weeks, adding to investors’ worries. Investors’ are therefore looking to Wednesday’s consumer price index release — which gauges…
[ad_1] carlosgaw/iStock via Getty Images Update 1.38 PM EST: Adds comments from Jefferies Alkermes (NASDAQ:ALKS) shares traded higher premarket Tuesday after the company announced that an early-stage trial for its investigational sleeping disorder therapy, ALKS 2680, indicated favorable data. Citing topline data from its Phase 1b study for ALKS 2680, the company said that the oral once-daily therapy outperformed placebo in patients with narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH). Alkermes (ALKS) noted that ALKS 2680, an orexin receptor agonist, indicated clinically meaningful and statistically significant improvements at all dose levels compared to placebo in relation to a clinical…
[ad_1] jetcityimage/iStock Editorial via Getty Images The construction of Eli Lilly’s (NYSE:LLY) $2.5B (€2.3B) manufacturing plant officially began in Germany this week as the U.S. drugmaker ramps up its production efforts to meet the demand for its popular weight loss therapy, tirzepatide. Located in the Western German town of Alzey, the plant will manufacture injectables, including tirzepatide and the pen-like devices used to inject the treatment. It will be the pharma industry’s largest investment since Germany’s reunification over three decades ago. “We are talking about one of, if not the biggest single investment in Germany as a pharmaceuticals location since…
[ad_1] A New York appeals court judge Tuesday rejected former President Donald Trump’s latest bid to delay his hush money criminal trial while he fights a gag order, clearing the way for jury selection to begin next week. Justice Cynthia Kern’s ruling is yet another loss for Trump, who has tried repeatedly to get the trial postponed. Trump’s lawyers had wanted the trial delayed until a full panel of appellate court judges could hear arguments on lifting or modifying a gag order that bans him from making public statements about jurors, witnesses and others connected to the hush-money case. The…
[ad_1] Some bitcoin miners won’t survive when the upcoming halving slashes their revenue in half, but the ones that do survive will thrive, and Rosenblatt Securities says TeraWulf is its top pick in the category. The firm initiated coverage of the bitcoin miner with a buy rating and $4.20 price target Tuesday. Shares were ahead almost 3% in early trading, bringing the past month’s gain to 14.2%. “WULF is our preferred way to allocate to bitcoin below spot prices, particularly among a not so shareholder-friendly pubco peer set,” Rosenblatt analyst Andrew Bond wrote in a note, referring to publicly traded miners. “While…
[ad_1] Many women dealing with job loss, lack of transportation and similar issues are skipping potentially lifesaving breast-cancer screenings, according to a new report from the U.S. Centers for Disease Control and Prevention. [ad_2] Source link